Literature DB >> 18556207

Antiprion activity of functionalized 9-aminoacridines related to quinacrine.

Thi Hanh Thuy Nguyen1, Chong-Yew Lee, Kenta Teruya, Wei-Yi Ong, Katsumi Doh-ura, Mei-Lin Go.   

Abstract

A library of functionalized 6-chloro-2-methoxy-(N(9)-substituted)acridin-9-amines structurally related to quinacrine were synthesized and evaluated for antiprion activity on four different cell models persistently infected with scrapie prion strains (ScN2a, N167, Ch2) or a human disease prion strain (F3). Most of the compounds were distinguished by the side chain attached to 9-amino of the acridine ring. These were dialkylaminoalkyl and phenyl with basic groups on the phenyl ring. The most promising compound was 6-chloro-2-methoxy-N-(4-(4-methylpiperazin-1-yl)phenyl)acridin-9-amine (15) which had submicromolar EC(50) values (0.1-0.7microM) on all cell models, was able to clear PrP(Sc) at non-toxic concentrations of 1.2-2.5microM, and was more active than quinacrine in terms of EC(50) values. Other promising compounds were 14 (a regioisomer of 15) and 17 which had a 1-benzylpiperidin-4-yl substituent attached to the 9-amino function. Activity was strongly dependent on the presence of a substituted acridine ring, which in this library comprised 6-chloro-2-methoxy substituents on the acridine ring. The side chains of 14, 15, and 17 have not been previously associated with antiprion activity and are interesting leads for further optimization of antiprion activity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18556207     DOI: 10.1016/j.bmc.2008.05.060

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  8 in total

1.  Prediction of antiprion activity of therapeutic agents with structure-activity models.

Authors:  Katja Venko; Špela Župerl; Marjana Novič
Journal:  Mol Divers       Date:  2013-09-20       Impact factor: 2.943

2.  Quinacrine promotes replication and conformational mutation of chronic wasting disease prions.

Authors:  Jifeng Bian; Hae-Eun Kang; Glenn C Telling
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-07       Impact factor: 11.205

3.  Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity.

Authors:  Valentina Villa; Michele Tonelli; Stefano Thellung; Alessandro Corsaro; Bruno Tasso; Federica Novelli; Caterina Canu; Albiana Pino; Katia Chiovitti; Domenico Paludi; Claudio Russo; Anna Sparatore; Antonio Aceto; Vito Boido; Fabio Sparatore; Tullio Florio
Journal:  Neurotox Res       Date:  2010-04-20       Impact factor: 3.911

Review 4.  Medicinal chemistry of acridine and its analogues.

Authors:  Parteek Prasher; Mousmee Sharma
Journal:  Medchemcomm       Date:  2018-08-14       Impact factor: 3.597

Review 5.  Pharmacological Agents Targeting the Cellular Prion Protein.

Authors:  Maria Letizia Barreca; Nunzio Iraci; Silvia Biggi; Violetta Cecchetti; Emiliano Biasini
Journal:  Pathogens       Date:  2018-03-07

Review 6.  Exploring Anti-Prion Glyco-Based and Aromatic Scaffolds: A Chemical Strategy for the Quality of Life.

Authors:  María Teresa Blázquez-Sánchez; Ana M de Matos; Amélia P Rauter
Journal:  Molecules       Date:  2017-05-24       Impact factor: 4.411

7.  Inhibition of RNA recruitment and replication of an RNA virus by acridine derivatives with known anti-prion activities.

Authors:  Zsuzsanna Sasvari; Stéphane Bach; Marc Blondel; Peter D Nagy
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

Review 8.  Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications.

Authors:  Wei-Yi Ong; Mei-Lin Go; De-Yun Wang; Irwin Kee-Mun Cheah; Barry Halliwell
Journal:  Mol Neurobiol       Date:  2020-09-08       Impact factor: 5.590

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.